Mutz Christopher (CIK 1846487) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-13). Recent activity: Sell ANIP (3,162 shares), Sell ANIP (2,121 shares), Sell ANIP (3,314 shares), Sell ANIP (3,602 shares), Sell ANIP (417 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 3,162 | $226,526 |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 2,121 | $157,421 |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 3,314 | $245,369 |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 3,602 | $267,196 |
| 2026-03-04 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 417 | $30,858 |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Buy | 21,306 | $1.6M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 2,221 | $164,132 |
| 2026-02-23 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 5,323 | $415,300 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 3,173 | $243,369 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 7,032 | $538,300 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 2,403 | $185,896 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 4,546 | $346,632 |
| 2025-05-15 | ANI PHARMACEUTICALS INC (ANIP) | HEAD OF RARE DISEASE | Sell | 4,000 | $241,800 |
Source: SEC Form 4 filings · as of 2026-03-13